SUZANNE HARTMANN: Open Payments
NPI 1558617134 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,681 in 128 payments from 31 companies in 2025. Trend: 2023 $2,720 · 2024 $3,112 · 2025 $2,681
Food & beverage: $2,681
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 35 | $597 |
| UCB, Inc. | 15 | $314 |
| PFIZER INC. | 11 | $235 |
| Lundbeck LLC | 8 | $218 |
| Boston Scientific Corporation | 2 | $179 |
| Neurocrine BioSciences, Inc. | 6 | $125 |
| Merz Pharmaceuticals, LLC | 5 | $111 |
| Axsome Therapeutics, Inc. | 6 | $110 |
| Eisai Inc. | 4 | $91 |
| ACADIA Pharmaceuticals Inc | 3 | $67 |
Products named: QULIPTA, UBRELVY, NURTEC ODT, VYEPTI, WaveWriter Alpha Prime 16, Briviact, Leqembi, INGREZZA.
Industry payments across NC — which companies pay providers there.
